(Q45849904)

English

Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate.

scientific article published in September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22817470%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22817470%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

based on heuristic

1 reference

based on heuristic

blood coagulation disease

1 reference

based on heuristic

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22817470%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

William P Sheffield

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22817470%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

M D Lambourne

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22817470%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

L J Eltringham-Smith

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22817470%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

S Gataiance

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22817470%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

D M Arnold

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22817470%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

1 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22817470%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22817470%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22817470%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22817470%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1830-1840

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22817470%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Managing oral anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

VKORC1: molecular target of coumarins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Management of excessive anticoagulant effect due to vitamin K antagonists

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Effect of study setting on anticoagulation control: a systematic review and metaregression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

The new oral anticoagulants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Neurosurgical complications of direct thrombin inhibitors--catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Comparative effectiveness of hemostatic therapy in experimental warfarin-associated intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Reversal of vitamin K antagonists prior to urgent surgery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Elevated function of blood clotting factor VIIa mutants that have enhanced affinity for membranes. Behavior in a diffusion-limited reaction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Reversal of drug-induced anticoagulation: old solutions and new problems

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Urgent reversal of warfarin with prothrombin complex concentrate: where are the evidence-based data?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Reversing anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04863.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45849904&oldid=1632109254"